About
60 Degrees Pharmaceuticals, Inc. Common Stock (NASDAQ:SXTP) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 15 2026
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
Mar 31 2026
60 Degrees Pharmaceuticals Announces 2025 Annual Results
Mar 18 2026
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
Mar 11 2026
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
Feb 2 2026
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
Financials
Revenue
$1.41 M
Market Cap
$4.69 M
EPS
-11.73
Translate